Deafness and goiter: Molecular genetic considerations

被引：18

作者：

Forrest, D

机构：

来源：

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | 1996年 / 81卷 / 08期

关键词：

D O I：

10.1210/jc.81.8.2764

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2764 / 2767

页数：4

共 16 条

[1] ALPHA-THYROID AND BETA-THYROID HORMONE-RECEPTOR (TR) GENE-EXPRESSION DURING AUDITORY NEUROGENESIS - EVIDENCE FOR TR ISOFORM-SPECIFIC TRANSCRIPTIONAL REGULATION IN-VIVO [J].

BRADLEY, DJ ;

TOWLE, HC ;

YOUNG, WS .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (02) :439-443

[2] Prevalence and mechanisms of hearing loss in patients with resistance to thyroid hormone [J].

BruckerDavis, F ;

Skarulis, MC ;

Pikus, A ;

Ishizawar, D ;

Mastroianni, MA ;

Koby, M ;

Weintraub, BD .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (08) :2768-2772

[3] GENETIC AND CLINICAL-FEATURES OF 42 KINDREDS WITH RESISTANCE TO THYROID-HORMONE - THE NATIONAL-INSTITUTES-OF-HEALTH PROSPECTIVE-STUDY [J].

BRUCKERDAVIS, F ;

SKARULIS, MC ;

GRACE, MB ;

BENICHOU, J ;

HAUSER, P ;

WIGGS, E ;

WEINTRAUB, BD .

ANNALS OF INTERNAL MEDICINE, 1995, 123 (08) :572-583

[4] Pendred syndrome (goitre and sensorineural hearing loss) maps to chromosome 7 in the region containing the nonsyndromic deafness gene DFNB4 [J].

Coyle, B ;

Coffey, R ;

Armour, JAL ;

Gausden, E ;

Hochberg, Z ;

Grossman, A ;

Britton, K ;

Pembrey, M ;

Reardon, W ;

Trembath, R .

NATURE GENETICS, 1996, 12 (04) :421-423

[5] EXPERIMENTAL APPROACH TO UNDERSTANDING AND TREATMENT OF HEREDITARY SYNDROMES WITH CONGENITAL DEAFNESS AND HYPOTHYROIDISM [J].

DEOL, MS .

JOURNAL OF MEDICAL GENETICS, 1973, 10 (03) :235-242

[6]

FORREST D, 1996, IN PRESS NATURE GENE

[7]

FORREST D, 1996, IN PRESS EMBO J

[8] DEVELOPMENTAL EXPOSURE TO POLYCHLORINATED-BIPHENYLS (AROCLOR-1254) REDUCES CIRCULATING THYROID-HORMONE CONCENTRATIONS AND CAUSES HEARING DEFICITS IN RATS [J].

GOLDEY, ES ;

KEHN, LS ;

LAU, C ;

REHNBERG, GL ;

CROFTON, KM .

TOXICOLOGY AND APPLIED PHARMACOLOGY, 1995, 135 (01) :77-88

[9]

KELLEY MW, 1993, DEVELOPMENT, V119, P1041

[10]

Pendred V., 1896, LANCET, V532, DOI [10.1016/S0140-6736(01)74403-0, DOI 10.1016/S0140-6736(01)74403-0, 10.1016/s0140-6736(01)74403-0]

← 1 2 →